Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.7K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Angiopoietin-like Protein 3 (ANGPTL3) Targeting in the Management of Dyslipidemias.

International journal of molecular sciences·2026
Same author

Lipid Profile and Management of Dyslipidemias in Pregnancy.

Journal of cardiovascular development and disease·2025
Same author

Combination of triglyceride-glucose index and waist-to-height ratio as a predictor of all-cause and cardiovascular mortality in adults with diabetes or prediabetes: a nationwide prospective cohort study.

Cardiovascular diagnosis and therapy·2025
Same author

Novel RNA-Based Therapies in the Management of Dyslipidemias.

International journal of molecular sciences·2025
Same author

Role of aspirin in the primary prevention of cardiovascular disease in patients with hyperlipoproteinaemia(a).

Drugs in context·2025
Same author

Lipoprotein (a) and cerebrovascular disease.

The Journal of international medical research·2024

Related Experiment Video

Updated: Feb 23, 2026

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing
11:09

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Published on: March 19, 2013

11.6K

Regenerative Stem Cell Therapy Optimization via Tissue Engineering in Heart Failure with Reduced Ejection Fraction.

Mehmet Alkan1, Raef Madanieh2, Niel N Shah2

  • 1College of Arts and Sciences, Brown University, Providence, RI, USA.

Cardiovascular Engineering and Technology
|August 30, 2017
PubMed
Summary

Heart failure (HF) is increasing globally, with limited regenerative treatments. Stem cell therapy shows promise for myocardial restoration in heart failure with reduced ejection fraction (HFrEF), but clinical application faces challenges.

Keywords:
Heart failureReduced ejection fractionRegenerative stem cell therapyStem cellTissue engineering

More Related Videos

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

8.1K
Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology
10:41

Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology

Published on: January 23, 2021

8.5K

Related Experiment Videos

Last Updated: Feb 23, 2026

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing
11:09

Generation of Aligned Functional Myocardial Tissue Through Microcontact Printing

Published on: March 19, 2013

11.6K
Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential
07:41

Simultaneous Electrical and Mechanical Stimulation to Enhance Cells' Cardiomyogenic Potential

Published on: January 18, 2019

8.1K
Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology
10:41

Cardiac Spheroids as in vitro Bioengineered Heart Tissues to Study Human Heart Pathophysiology

Published on: January 23, 2021

8.5K

Area of Science:

  • Regenerative Medicine
  • Cardiovascular Research
  • Biotechnology

Background:

  • Rising global prevalence of heart failure (HF).
  • Current HF therapies offer palliative care, lacking myocardial regenerative capacity.
  • Poor prognosis for patients with heart failure with reduced ejection fraction (HFrEF).

Purpose of the Study:

  • To review foundational work in cardiac stem cell therapy for HFrEF.
  • To discuss advantages and limitations of stem cell candidates for myocardial restoration.
  • To explore mechanisms of action, scaffolding, and clinical application challenges.

Main Methods:

  • Literature review of cardiac stem cell therapy research.
  • Analysis of stem cell candidates for tissue regeneration.
  • Examination of scaffolding materials and clinical hurdles.

Main Results:

  • Stem cell therapy demonstrates potential for myocardial restoration in HFrEF.
  • Various stem cell types show promise but have limitations.
  • Scaffolding materials and clinical challenges require further investigation.

Conclusions:

  • Stem cell therapy offers a promising regenerative approach for HFrEF.
  • Addressing current limitations is crucial for widespread clinical adoption.
  • Further research into mechanisms, materials, and clinical translation is needed.